322 related articles for article (PubMed ID: 29990500)
1. Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution.
Shain AH; Joseph NM; Yu R; Benhamida J; Liu S; Prow T; Ruben B; North J; Pincus L; Yeh I; Judson R; Bastian BC
Cancer Cell; 2018 Jul; 34(1):45-55.e4. PubMed ID: 29990500
[TBL] [Abstract][Full Text] [Related]
2. The Genetic Evolution of Melanoma from Precursor Lesions.
Shain AH; Yeh I; Kovalyshyn I; Sriharan A; Talevich E; Gagnon A; Dummer R; North J; Pincus L; Ruben B; Rickaby W; D'Arrigo C; Robson A; Bastian BC
N Engl J Med; 2015 Nov; 373(20):1926-36. PubMed ID: 26559571
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathway activation features linked with transition from normal skin to primary and metastatic melanomas in human.
Shepelin D; Korzinkin M; Vanyushina A; Aliper A; Borisov N; Vasilov R; Zhukov N; Sokov D; Prassolov V; Gaifullin N; Zhavoronkov A; Bhullar B; Buzdin A
Oncotarget; 2016 Jan; 7(1):656-70. PubMed ID: 26624979
[TBL] [Abstract][Full Text] [Related]
4. Lack of distinct molecular profile of Primary Dermal Melanoma.
Shaigany S; Tessier-Cloutier B; Busam KJ; Horst BA
Hum Pathol; 2020 Dec; 106():32-38. PubMed ID: 32946880
[TBL] [Abstract][Full Text] [Related]
5. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
[TBL] [Abstract][Full Text] [Related]
6. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Liu-Smith F; Jia J; Zheng Y
Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
[TBL] [Abstract][Full Text] [Related]
7. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
Lázár V
Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
[TBL] [Abstract][Full Text] [Related]
8. The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells.
Slipicevic A; Jørgensen K; Skrede M; Rosnes AK; Trøen G; Davidson B; Flørenes VA
BMC Cancer; 2008 Sep; 8():276. PubMed ID: 18826602
[TBL] [Abstract][Full Text] [Related]
9. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
[No Abstract] [Full Text] [Related]
10. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.
Takata M; Murata H; Saida T
Pigment Cell Melanoma Res; 2010 Feb; 23(1):64-71. PubMed ID: 19788535
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma.
Jensen EH; Lewis JM; McLoughlin JM; Alvarado MD; Daud A; Messina J; Enkemann S; Yeatman TJ; Sondak VK; Riker AI
Ann Surg Oncol; 2007 Apr; 14(4):1416-23. PubMed ID: 17195911
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics-based analysis reveals elevated MFSD12 as a key promoter of cell proliferation and a potential therapeutic target in melanoma.
Wei CY; Zhu MX; Lu NH; Peng R; Yang X; Zhang PF; Wang L; Gu JY
Oncogene; 2019 Mar; 38(11):1876-1891. PubMed ID: 30385854
[TBL] [Abstract][Full Text] [Related]
13. Transcript levels of keratin 1/5/6/14/15/16/17 as potential prognostic indicators in melanoma patients.
Han W; Hu C; Fan ZJ; Shen GL
Sci Rep; 2021 Jan; 11(1):1023. PubMed ID: 33441834
[TBL] [Abstract][Full Text] [Related]
14. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
[TBL] [Abstract][Full Text] [Related]
15. IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence.
Itakura E; Huang RR; Wen DR; Paul E; Wünsch PH; Cochran AJ
Mod Pathol; 2011 Jun; 24(6):801-9. PubMed ID: 21317876
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.
Hoek K; Rimm DL; Williams KR; Zhao H; Ariyan S; Lin A; Kluger HM; Berger AJ; Cheng E; Trombetta ES; Wu T; Niinobe M; Yoshikawa K; Hannigan GE; Halaban R
Cancer Res; 2004 Aug; 64(15):5270-82. PubMed ID: 15289333
[TBL] [Abstract][Full Text] [Related]
17. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
[TBL] [Abstract][Full Text] [Related]
18. Use of human tissue to assess the oncogenic activity of melanoma-associated mutations.
Chudnovsky Y; Adams AE; Robbins PB; Lin Q; Khavari PA
Nat Genet; 2005 Jul; 37(7):745-9. PubMed ID: 15951821
[TBL] [Abstract][Full Text] [Related]
19. Ultraviolet light and melanoma.
Craig S; Earnshaw CH; Virós A
J Pathol; 2018 Apr; 244(5):578-585. PubMed ID: 29380860
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of the melanoma transcriptome.
Berger MF; Levin JZ; Vijayendran K; Sivachenko A; Adiconis X; Maguire J; Johnson LA; Robinson J; Verhaak RG; Sougnez C; Onofrio RC; Ziaugra L; Cibulskis K; Laine E; Barretina J; Winckler W; Fisher DE; Getz G; Meyerson M; Jaffe DB; Gabriel SB; Lander ES; Dummer R; Gnirke A; Nusbaum C; Garraway LA
Genome Res; 2010 Apr; 20(4):413-27. PubMed ID: 20179022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
